The regulation of similar biotherapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Forum 2019 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Brazil and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?

More than:








Managing Directors

Managers and Specialists

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance

Programme at a Glance

Regulatory Update - Brazil
Best Practice: How to get move a biosimilar in an emerging market?
Regulatory Agencies´ Efforts to Increase Biosimilars Access in Latam
Risk Management Plan - Pharmacovigilance in Latam
Tailoring Pharmacovigilance to Changing Regulatory Standards
Panel: How Can Regulation on Biosimilars be Consolidated in the Region?
Challenges and Opportunities for the Legal and Compliance Environment of Biosimilars in Latin America.
Panel: The Latam Industry Approach
Panel: Evaluating the 5+ Years of PDP Project
Is traceability useful for interchangeability?
Panel with leaders: What the Future of Biosimilars Is?
Full programme in the PDF Agenda

Highlights from Biosimilars Latam 2018, Mexico

Keep me updated

About "JackLeckerman"

JackLeckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2019 JackLeckerman. All Rights Reserved. Designed By